Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × temsirolimus × Clear all

NCT01026792 2015-09-10

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Phase 2 Completed

38 enrolled 5 charts

Uterine Cervical Neoplasms